The age-dependency of genetic and environmental influences on serum cytokine levels: A twin study

Cytokine

Volumn 60, Issue 1, 2012, Pages 108-113

  Sas, Arthur A ^a   Jamshidi, Yalda ^b   Zheng, Dongling ^b   Wu, Ting ^a   Korf, Jakob ^a   Alizadeh, Behrooz Z ^a   Spector, Tim D ^c   Snieder, Harold ^a,c  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Aging; Cytokines; Heritability; Interleukin; Twins

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE; ARTICLE; DIZYGOTIC TWINS; ENVIRONMENTAL FACTOR; FEMALE; HEREDITY; HUMAN; IMMUNE RESPONSE; MONOZYGOTIC TWINS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STRUCTURAL EQUATION MODELING; TWINS; UNITED KINGDOM;

AGED; AGING; ANALYSIS OF VARIANCE; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; MIDDLE AGED; MODELS, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; TWINS, DIZYGOTIC; TWINS, MONOZYGOTIC;

EID: 84865429248     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.04.047     Document Type: Article

References (28)

1. Wang J., Zhang S., Wang Y., Chen L., Zhang X.S. Disease-aging network reveals significant roles of aging genes in connecting genetic diseases. PLOS Comput Biol 2009, 5:e1000521.
2. Anderson R.M., Shanmuganayagam D., Weindruch R. Caloric restriction and aging: studies in mice and monkeys. Toxicol Pathol 2009, 37:47-51.
3. Ostojić S., Pereza N., Kapovic M. A current genetic and epigenetic view on human aging mechanisms. Coll Antropol 2009, 33:687-699.
4. Franceschi C., Bonafè M., Valensin S., Olivieri F., De Luca M., Ottaviani E., et al. An evolutionary perspective on immunosenescence. Ann NY Acad Sci 2000, 908:244-254.
5. Franceschi C., Capri M., Monti D., Giunta S., Olivieri F., Sevini F., et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 2007, 128:92-105.
6. Vasto S., Candore G., Balistreri C.R., Caruso M., Colonna-Romano G., Grimaldi M.P., et al. Inflammatory networks in ageing, age-related diseases and longevity. Mech Ageing Dev 2007, 128:83-91.
7. Pawelec G., Effros R.B., Caruso C., Remarque E., Barnett Y., Solana R. T-cells and aging. Front Biosci 1999, 4:216-269. [update February 1999].
8. Bruunsgaard H., Pedersen M., Pedersen B.K. Aging and pro-inflammatory cytokines. Curr Opin Hematol 2001, 8:131-136.
9. Schnabel R.B., Lunetta K.L., Larson M.G., Dupuis J., Lipinska I., Rong J., et al. The relation of genetic and environmental factors to systemic inflammatory biomarker concentrations. Circ Cardiovasc Genet 2009, 2:229-237.
10. Danesh J., Collins R., Appleby P., Peto L. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998, 279:1477-1482.
11. Luc G., Bard J.M., Juhan-Vague I., Ferrieres J., Evans A., Amouyel P., et al. PRIME study group. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME study. Arterioscler Thromb Vasc Biol 2003, 23:1255-1261.
12. Pantsulaia I., Trofimov S., Kobyliansky E., Livshits G. Genetic and environmental influences on IL-6 and TNF-α plasma levels in apparently healthy general population. Cytokine 2002, 19:138-146.
13. Rahman I., Bennet A.M., Pedersen N.L., de Faire U., Svensson P., Magnusson P.K. Genetic dominance influences blood biomarker levels in a sample of 12,000 Swedish elderly twins. Twin Res Hum Gen 2009, 12:286-294.
14. Su S., Miller A.H., Snieder H., Bremner J.D., Ritchie J., Maisano C., et al. Common genetic contributions to depressive symptoms and inflammatory markers in middle-aged men: the twins heart study. Psychosom Med 2009, 71:152-158.
15. De Maat M.P., Bladbjerg E.M., Hjelmborg J.B., Bathum L., Jespersen J., Christensen K. Genetic influence on inflammation variables in the elderly. Arterioscl Tromb Vasc Biol 2004, 24:2168-2173.
16. Dinarello C.A. Biologic basis for Interleukin-1 in disease. Blood 1996, 87:2095-2147.
17. Locksley R.M., Killeen N., Lenardo M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001, 104:487-501.
18. Gauldie J., Richards C., Northemann W., Fey G., Baumann H. IFNB2/BSF2/IL-6 is the monocyte-derived HSF that regulates receptorspecific acute phase gene regulation in hepatocytes. Ann NY Acad Sci 1989, 557:46-59.
19. Jylhä M., Paavilainen P., Lehtimäki T., Goebeler S., Karhunen P.J., Hervonen A., et al. Interleukin-1 receptor antagonists, Interleukin-6, and C-reactive protein as predictors of mortality in nonagenarians: the Vitality 90+ study. J Gerontol 2007, 9:1016-1021.
20. Lio D., Scola L., Crivello A., Colonna-Romano G., Candore G., Bonafè M., et al. Gender-specific association between -1082 IL-10 promoter polymorphism and longevity. Genes Immun 2001, 3:30-33.
21. Moore K.W., De Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin 10 and the interleukin receptor. Annu Rev Immunol 2001, 19:683-765.
22. Spector T.D., Williams F.M.K. The UK adult twin registry (TwinsUK). Twin Res Human Gene 2006, 9:899-906.
23. Neale M.C., Cardon L.R. Methodology for genetic studies in twins and families 1992, Kluwer Academic, Dordrecht.
24. Purcell S. Variance components models for gene-environment interaction in twin analysis. Twin Res 2002, 5:554-571.
25. Neale M.C., Boker S.M., Xie G., Maes H.H. Mx: statistical modeling 1999, Virginia Commonwealth University, Richmond.
26. Su S., Snieder H., Miller A.H., Ritchie J., Bremner J.D., Goldberg J., et al. Genetic and environmental influences on systemic markers of inflammation in middle-aged male twins. Atherosclerosis 2008, 200:213-220.
27. Wörns M.A., Victor A., Galle P.R., Höhler T. Genetic and environmental contributions to plasma C-reactive protein and interleukin-6 levels-a study in twins. Genes Immun 2006, 7:600-605.
28. Dupuis J., Larson M.G., Vasan R.S., Massaro J.M., Wilson P.W., Lipinska I., et al. Genome scan of systemic biomarkers of vascular inflammation in the Framingham Heart Study: evidence for susceptibility loci on 1q. Atherosclerosis 2005, 182:307-314.